Neovasc provides distinctive medical device solutions with a suite of products for unmet needs in vascular intervention.
Our products include the Metricath® for intravascular measurement, Peripatch™ biologic surgical patch, Peripatch™ Aegis for staple line reinforcement and a pipeline of innovative products under development, including the Reducer stent for refractory angina.
Neovasc works closely with physicians to understand and address the clinical challenges they face, and we are investigating a range of additional technologies and products for vascular medicine.
Neovasc is headquartered in Vancouver, B.C., Canada. Our products are distributed around the world.
At Neovasc, we develop and market specialized vascular products that address unmet clinical needs. Our products are intended to allow physicians to more quickly and effectively undertake vascular surgery, angioplasty and related procedures.
Metricath - precise lumen and stent measurement
Reducer - a breakthrough, minimally invasive treatment for refractory angina
Ostial balloon and stent products
Read clinical reports about Neovasc products
Neovasc produces Peripatch™, a suite of tissue-based patch devices for use in cardiac, vascular and general surgery. These safe, natural, biocompatible products help repair soft tissue in surgical patients.
We also offer a surgical buttress material for use with traditional endoscopic staplers in bariatric or thoracic surgery. The Peripatch™ Aegis reinforces the staple line to minimize the risk of post-operative leaks and resulting complications.
We develop our products using a proprietary tissue-processing technology with an over 15-year history of safety and efficacy.
Neovasc also offers contract manufacturing, OEM, and device development consulting services.
| Neovasc Completes First Tranche Of $1.329 Million Non-Brokered Private Placement | 01/28/2010 - 08:00 | $1Million |
| Neovasc To Raise Up To $2 Million In Non-Brokered Private Placement | 01/07/2010 - 08:00 | $2Million |
| Neovasc Completes $2 Million Non-Brokered Private Placement | 04/24/2009 - 07:00 | $2Million |
| Neovasc To Raise $2 Million In Non-Brokered Private Placement | 03/30/2009 - 07:00 | $2Million |
| Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing | 07/02/2008 - 07:00 | $8Million |